To: Board of Supervisors
From: Anna Roth, Health Services Director
Report Title: Amendment #76-753-3 with DiaSorin Inc.
?Recommendation of the County Administrator ? Recommendation of Board Committee
RECOMMENDATIONS:
APPROVE and AUTHORIZE the Health Services Director, or designee, to execute on behalf of the County Contract Amendment Agreement #76-753-3 with DiaSorin Inc., a corporation, effective June 25, 2024, to amend Contract #76-753 (as amended by Contract Amendment Agreements #76-753-1 and #76-753-2), for additional reagents for the Clinical Laboratory at the Contra Costa Regional Medical Center (CCRMC) and Health Centers with no change in the payment limit of $552,221 or term ending May 31, 2026.
FISCAL IMPACT:
Approval of this Amendment will result in no change to the original budgeted expenditures of up to $552,221 and funded 100% by Hospital Enterprise Fund I. (No rate increase)
BACKGROUND:
This Contract meets the medical needs of the County's population by enhancing systems to improve efficiency in CCRMC's immunoassay laboratories. The CCRMC Clinical Laboratory uses DiaSorin Inc. for reagents and supplies for patient specimen testing specific to the analyzer used for testing. Among the tests conducted are those for measles, mumps, rubella, and many others. DiaSorin Inc. provides all the supplies needed for such testing. These tests are crucial for patients who suffer from various illnesses. The Liaison XL Analyzer is a fully automated chemiluminescence analyzer that performs complete sample processing and runs antigen-antibody assays. This Amendment was approved by Health Services Personnel consistent with procedures established by the Labor Relations Division of the County Administrator's Office.
On July 27, 2021, the Board of Supervisors approved Contract #76-753 with DiaSorin Inc., in an amount not to exceed $495,000, for the purchase and services for a Liaison XL Analyzer utilized by the Clinical Laboratory at CCRMC for specimen testing and rea...
Click here for full text